Results 151 to 160 of about 1,265,387 (249)

Polatuzumab Vedotin Induced CD20 Upregulation Contributes to the Efficacy of Mosunetuzumab in Combination With Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma Preclinical Models. [PDF]

EJHaem
Kawasaki N, Shu S, Tomita M, Liu X, Yoshiura S, Yamashita-Kashima Y.   +5 more
europepmc   +1 more source

Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: a real-world study. [PDF]

Ann Hematol
Yamada T, Nakamura N, Goto H, Hara T, Kasahara S, Fukuno K, Sawada M, Nakamura H, Hayase N, Goto T, Suzaki T, Fujita K, Lee S, Kanemura N, Shimizu M, Tsurumi H.   +15 more
europepmc   +1 more source

Structural characterization of atrial natriuretic peptide amyloid fibrils from patients with atrial fibrillation. [PDF]

Nat Commun
Broggini L, Piccoli M, Chaves-Sanjuan A, Bonnet DMV, Cirillo F, Visentin C, Sonzini F, Signorelli P, Lavota I, Milazzo M, Nonnis S, Menicanti L, Ciconte G, Pappone C, Anastasia L, Ricagno S.   +15 more
europepmc   +1 more source

First-line treatment with polatuzumab vedotin improves efficacy and survival in newly diagnosed patients with advanced diffuse large B-cell lymphoma: a multicentre retrospective analysis. [PDF]

Ann Med
Bai SJ, Shen XL, Tian WW, Liu ZY, Lang JY, Gao YN, Zhang CX, Wang YR, Geng Y, Shi YX, Liu Q, He JX.   +11 more
europepmc   +1 more source

Advantages of 3D printing for soldiers’ clothing and equipment [PDF]

, 2015
Pola, Taina
core  

Antibody-Drug Conjugates in Hematological Malignancies: Current Landscape and Future Perspectives. [PDF]

Int J Mol Sci
Montalbano MC, Micillo M, Deaglio S, Vaisitti T.   +3 more
europepmc   +1 more source

Comparative analysis of enamel mineral content and surface morphology alterations after bleaching: a study using colorimetric spectrophotometry and scanning electron microscopy. [PDF]

Front Dent Med
Kuruba A, Bolbandi GI, Desai SR, Indi S, Mustafa M, Alshehri AM, Alqahtani AR, Alanazi KK, Almuhaiza M, Alghannam S.   +9 more
europepmc   +1 more source

Mechanical and mineralogical performance of sustainable cement composites with calcined palm oil leaf and calcined pine leaf Ash as supplementary cementitious materials. [PDF]

Sci Rep
Samadi M, Murali G, Wong LS, Din NM, Abdulkadir I, Abdellatief M, Abdul Shukor Lim NH, Mebrate Z.   +7 more
europepmc   +1 more source

Real-world treatment patterns and clinical outcomes among patients with diffuse large B-cell lymphoma in a US healthcare claims database. [PDF]

Blood Cancer J
Shadman M, Harper JS, Bokun A, Xu C, Lin P, Graf G, Lu X.   +6 more
europepmc   +1 more source

Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial. [PDF]

J Clin Oncol
Budde LE, Zhang H, Kim WS, Maruyama D, Rego EM, Norasetthada L, Hong H, Ozcan M, Jeon YW, Leão Cordeiro de Farias D, Fogliatto LM, Pavlovsky A, Goto H, Olszewski AJ, Shah N, Hu B, Yin S, Wu H, To I, Ead WS, Ashby J, Janousek M, Pham S, Wang J, Kwan A, Batlevi CL, Wei MC, Westin J.   +27 more
europepmc   +1 more source